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Abstract
Background: There is increasing interest in interventions that can support patients who face difficult
decisions and individuals who need to modify their behaviour to achieve better outcomes. Evidence for
effectiveness is used to categorise patients care. Effective care is where evidence of benefit outweighs
harm: patients should always receive this type of care, where indicated. Preference-sensitive care describes
a situation where the evidence for the superiority of one treatment over another is either not available or
does not allow differentiation; in this situation, there are two or more valid approaches, and the best
choice depends on how individuals value the risks and benefits of treatments.
Discussion: Preference-sensitive decisions are defined by equipoise: situations where options need to be
deliberated. Moreover, where both healthcare professionals and patients agree that equipoise exists,
situations may be regarded as having 'dual equipoise'. Such conditions are ideal for shared decision making.
However, there are many situations in medicine where dual equipoise does not exist, where health
professionals hold the view that scientific evidence for benefit strongly outweighs harm. This is often the
case where people suffer from chronic conditions, and where behaviour change is recommended to
improve outcomes. However, some patients, are either ambivalent or find it difficult to sustain optimal
behaviours, i.e., patients will be in varying degrees of equipoise. Therefore, situations where dual equipoise
exists (or not) help to clarify the definitions of two classes of support, namely, decision and behaviour
change support interventions. Decision support interventions help people think about choices they face;
they describe where and why choice exists, in short, conditions of dual equipoise; they provide information
about options, including, where reasonable, the option of taking no action. These interventions help people
to deliberate, independently or in collaboration with others, about options by considering relevant
attributes; they support people to forecast how they might feel about short, intermediate, and long-term
outcomes that have relevant consequences, in ways that help the process of constructing preferences and
eventual decision making appropriate to their individual situation. Whereas, behavioural support
interventions describe, justify, and recommend actions that, over time, lead to predictable outcomes over
short, intermediate, and long-term timeframes, and that have relevant and important consequences for
those who are considering behaviour change.
Summary: Decision and behaviour support interventions have divergent aims, different relationships to
equipoise, and form two classes of interventions.
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Background
The interest in creating interventions that help patients to
make decisions about treatments or tests, or to help peo-
ple considering immunisations, screening tests, and other
choices in healthcare, has led to substantial debate in how
these tools should be developed, designed, and imple-
mented [1]. Although interventions to support decision
making have been developed in decision science for over
50 years, it is only over the last decade or so that we have
seen a significant interest in interventions specifically
designed for patients. These interventions are known by a
number of different names (shared decision-making pro-
grams, decision aids, decision support tools or technolo-
gies), a nomenclature indicative of a field that has
developed rapidly since the late 1990s [2]. The increasing
number of such interventions underlines the fact that
medicine is undergoing a significant shift in how the roles
of physician and patient are defined. At the heart of this
shift is the recognition that decisions in medicine need to
accommodate two key issues that reflect societal shifts in
how expertise is viewed [3]. First, that significant uncer-
tainty exists about the benefit versus harm ratio of many
medical tests and treatments. Second, and largely because
such uncertainty is increasingly being acknowledged,
there is widening agreement that the unilateral imposi-
tion of professional opinion about how to manage clini-
cal problems--an approach often labelled as paternalism-
-is no longer a valid mode of interaction in healthcare set-
tings. We recognise that patients have always acted as
autonomous agents when it comes to their actual behav-
iour, a phenomenon that largely explains low adherence
to prescribed medication. As a consequence, interactions
in healthcare now need to acknowledge that often a bal-
ance exists between harm and benefit of different options-
-a concept we call 'equipoise' and that we will describe in
greater detail [4]. In short, patients are increasingly expect-
ing to be informed and involved in the process of care.
This shift towards collaboration is not only relevant when
people face difficult decisions where there are high stakes,
'narrow window of opportunities,' and where outcomes
are uncertain, but also in situations where people need to
manage long-term conditions or might want to consider
making changes to their lifestyles in order to reduce future
risks--in other words, conditions where there are long
timeframes and, although the stakes are still high, the
urgency is less pressing.
Health professionals are finding this role-shift challeng-
ing, and although pre- and postgraduate training curricula
have adopted patient-centred models over the last two
decades, there is evidence that practitioners struggle to
incorporate patient agendas [5], seldom ask about their
fears and expectations, and are unable to put shared deci-
sion making and behaviour change counselling into prac-
tice into their day-to-day routines. Although we could
conjecture about the underpinning reasons for this, we
focus this article on the interest that has emerged over the
last decade in interventions to more actively involve
patients in their care, be they in paper-based formats such
as leaflets or booklets, or videotapes, compact video disks,
or web-based tools. We wish to place these tools in the
context of the wider literature concerned with the devel-
opment and implementation of complex interventions to
implement 'best practice' [6]. In addition, we wish to
define the core components of these interventions in
order to clarify the minimal requirements for classifica-
tion, and to examine whether or not there is a need to
have more than one class of intervention support.
Discussion
In the late 1980s, a group of clinician-researchers in Bos-
ton [7] built on Wennberg's research showing that medi-
cal practice variation cannot be explained by varying
disease prevalence [8]. Wennberg proposed dividing med-
ical care into different types of care, which include 'effec-
tive' and 'preference-sensitive' care. Effective care is
founded on strong evidence of effectiveness, which
patients should always receive, where indicated. Prefer-
ence-sensitive care on the other hand describes a situation
where the evidence for the superiority of one treatment
over another is not available; there are therefore two or
more valid approaches to care and the best choice
depends on how a patient values the risks and benefits of
the treatments available. This work led to the definitions
of unwarranted variation in preference-sensitive care as
being due to a combination of different professional prac-
tice typically seen in different geographical areas, and a
failure to adequately incorporate patient preferences into
decision-making processes [9]. This distinction is ratified
by the Grading of Recommendations Assessment, Devel-
opment and Evaluation (GRADE) Working Group, which
draws distinction between strong and weak practice rec-
ommendations, based on the quality rating of evidence,
and also advocates that patient preferences are key to deci-
sion making in situations where weak recommendations
exist [10].
Therefore, the need for clinicians to work collaboratively
with patients in preference-sensitive decisions led to the
creation of shared decision-making programs and the
establishment, over time, of the Foundation for Informed
Medical Decision Making [11]. Around the same time,
O'Connor published work on the elicitation of patient
preferences [12]. In 1998, an article appeared in which the
term 'decision aids' was used to describe an intervention
designed to help women consider whether or not to use
hormone replacement therapy [13]. This was to be the
first of many descriptions and evaluations of decision aids
at the Ottawa Health Research Institute, and was the basis
for many developments in this field. It was from these
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beginnings that the work began of collating an evidence
base for the effectiveness of decision aids, resulting in a
Cochrane Review [14]. In summary, these interventions
are reported to have positive outcomes, such as improved
user knowledge, accuracy of risk perceptions, satisfaction
with decision making, to patients taking more conserva-
tive approaches to healthcare, and to greater clarity about
their personal preferences [14].
The most recent development has been the creation of a
set of quality standards based on reviews of evidence per-
taining to a number of relevant quality dimensions for
these interventions. The work has been co-ordinated by
the International Patient Decision Aids Collaboration
(IPDAS). A two-round modified Delphi consensus proc-
ess resulted in the publication of a checklist [1] and, more
recently, the establishment of an instrument that is capa-
ble of generating a quality score that will facilitate a qual-
ity assessment service and benchmarking exercise [15].
There will, no doubt, be debate about the applicability of
these standards and concerns about the tendency for
standards to restrict innovation and experimentation.
Nevertheless, they signal a need for developers and
researchers to pay attention to the active ingredients of
decision support interventions. In parallel, there are also
indications that researchers who have been concerned
with the development and quality of clinical guidelines
are also working on the need to involve patients, not only
to make them accessible and relevant to patients' needs,
but also to involve patients in their production and eval-
uation [16]. It is a short step, therefore, before clinical
guidelines, if they come to be explicit about the availabil-
ity of treatment options in many situations, will also qual-
ify to be considered as decision support interventions
[17].
Significant investments are being made in the develop-
ment of decision support interventions, more recently
including tools to help patients deal with long-term con-
ditions (chronic diseases) [18,19]. Considerable efforts
are being undertaken to implement these tools in real-
world settings, with many developers viewing these inter-
ventions as products in a marketplace, encouraged by pol-
icies that encourage the convergence of commoditised
healthcare, informed choice, and client-centred service
design [20,21]. However, many questions remain unre-
solved. The role of patients' stories (narratives or testimo-
nials) in these interventions is debated [22]. Such
narrative elements have undoubted impact, so how to
achieve balance remains problematic. In addition, how to
best support a deliberation process is unresolved. Should
people be encouraged to undertake exercises to clarify
their preferences and consider competing attributes of
options, or should these processes be left implicit, leaving
individuals to rely on inherent heuristic approaches [23]
and intuition [24]. These uncertainties will remain until
further research emerges, but these tools will nevertheless
continue to be produced and promoted [20].
Preference sensitive decisions: situations of dual equipoise
O'Connor's defines decision aids as 'interventions
designed to help people make specific and deliberative
choices among options by providing information about
the options and outcomes that are relevant to a person's
health status' [14]. This definition rests on the assumption
that healthcare contexts exist where it is reasonable to
offer choice [19]. We contend that this, in turn, rests on
the concept of equipoise--the existence of options that are
in balance in terms of their attractiveness, or that the out-
comes are to, a degree at least, equally desirable (or possi-
bly, undesirable) [4]. This balance between options need
not be perfect, indeed it is doubtful whether for any one
individual that perfect equipoise between choices ever
exists; but insofar as is reasonable, equipoise can be
deemed to exist when a majority of people would agree
that it is reasonable to consider making a choice between
competing options.
Most decision support interventions have been developed
to tackle preference-sensitive decisions where equipoise
exists. A good example is the situation where a woman has
been diagnosed with early stage breast cancer and needs to
decide whether to have surgery that removes or conserves
the breast (mastectomy or breast conservation) [25]. In
this situation, the decision is relatively urgent, cannot be
deferred indefinitely, and, moreover, is a difficult one to
make because there is more than one option that can be
considered. Research indicates that the outcomes of mas-
tectomy and breast conservation surgery are more or less
comparable in terms of mortality, but that important dif-
ferences exist for patients' quality of life [26,27]. Health
professionals recognise this decision as one where there
mortality outcomes are sufficiently equivalent for many
individual circumstances to allow patient preferences to
choose the surgical procedure. Patients, once knowing
this equivalence, understand that it is a preference-sensi-
tive decision because they place differential emphases on
issues such as breast conservation, body image, sexuality,
and recurrence rates of local cancer. This decision can
therefore be considered to have dual equipoise, where
both health professionals and patients, once informed,
agree conceptually that individual preferences are accept-
able arbitrators of choice. We propose that professionally-
situated equipoise is a pre-condition to the existence of
dual equipoise interactions, and that these in turn facili-
tate shared decision making, and, as a result, are a pre-
condition for the implementation of decision support
interventions. Examining this proposal, we suggest that
dual equipoise helps both the professional and the
patient accept the validity of discussing options, helps
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patients to understand why their preferences are relevant
and that the option attributes deserve deliberative
thought in which counterfactual (what if) situations are
considered. In short, these interventions provide individ-
uals with the opportunity to construct and forecast prefer-
ences about their short, intermediate, and long-term
outcomes. Given these characteristics, the consideration
of surgical options in early breast cancer unequivocally
meets dual equipoise criteria--it has reasonable, available
options that need to be carefully deliberated.
Yet, we need to immediately recognise that the acceptance
of equipoise remains one of the most difficult issues in
clinical practice and, in addition, for patients to under-
stand, given that it requires an acceptance that there is no
right answer. For example, the decision for a man to be
tested for the prostate specific antigen is accepted to be
preference-sensitive and where decision support interven-
tions are advocated [28-30]. But in practice, neither
patients nor medical practitioners act accordingly: the
public perception, abetted by media campaigns, seldom,
if ever promotes the concept of equipoise around this
decision; so the role of decision support interventions,
their provenance, and their promotion becomes vital, and
even more controversial in determining the best course of
action. There is a requirement to see decisions like this in
a broader context and to consider consequences across
longer-term time horizons.
These arguments bring us to a proposed definition: deci-
sion support interventions help people think about
choices they face; they describe where and why choice
exists, in short, conditions of dual equipoise; they provide
information about options, including, where reasonable,
the option of taking no action. These interventions help
people to deliberate, independently or in collaboration
with others, about options by considering relevant
attributes; they support people to forecast how they might
feel about short, intermediate, and long-term outcomes
that have relevant consequences in ways that help the
process of constructing preferences and eventual decision
making appropriate to their individual situation [31].
This is a broad definition, but it does require clarity about
the nature of equipoise and whether the equipoise is
located in one or more actor in any given interaction, an
issue to which we return. It requires information provi-
sion, and the presence of two or more options, accepting
that taking no action is in some cases an acceptable
option. Decision support interventions offer no guidance
about exactly how individuals should undertake the task
of deliberation. We take the view that we do not yet have
sufficient evidence on which to stipulate such an addition.
When we examine decision support interventions from
this vantage point, we notice that the majority of interven-
tions have tackled decisions that we regard as having dual
equipoise, where professionals (or at least professionals
who are willing to acknowledge uncertainty, in its many
guises, and help patients become involved in decisions)
are willing to spend time introducing the concept of
choice and undertake the inevitable additional work of
addressing the questions and anxieties that arise [32]. We
need here to also address the issue of terminology. We
have chosen to use the term 'decision support interven-
tion' in preference to the more widely used term 'decision
aid'. We do this in order to draw attention to the issue that
the term aid may not sufficiently encompass the range of
potential interventions that are being developed and
tested, for example, the arrival of multi-media web-based
interactive and collaborative social network media. We
also will inevitably need to refocus our evaluation beyond
the artefact itself and to recognise that these tools are
examples of embedded complex interventions [6], where
the issues of how they are used, when, and by who will
contribute to as much to their potential impact as the con-
tent of the artefact.
Situations without dual equipoise
It follows therefore that here are also situations that lack
dual equipoise. These are situations where strong evi-
dence exists in favour of specific treatments or tests, or
where there is a clear consensus that one approach is supe-
rior over another or that a change in lifestyle leads to
greater benefit than harm. In Wennberg's categorization,
this is known as effective care. Perhaps some will argue
that we are overlooking patients' rights of self-determina-
tion, and that the principles of patient autonomy should
apply even when professionals hold views about effective
care. This is not the case. Indeed, we argue that excellent
clinicians will explore patient agendas to the full, no mat-
ter how much those agendas run counter to prevailing sci-
entific views. However, we also wish to see patient
involvement flourish in real clinical settings. In situations
where benefits clearly outweigh harms, professionals will
not regard them as having dual equipoise and the deliber-
ations will not be considered worth the investment
required to achieve shared decision making. In other
words, we are pragmatists more than we are ethicists who
support mandatory autonomy [33].
A good example of this kind of situation--and one that cli-
nicians face daily--is supporting a patient managing a
long-term condition. For the majority of these conditions,
there is good evidence that links specific processes to good
outcomes--either adhering to medication or modifying
lifestyle. Achieving the goals of good control for high
blood pressure, diabetes, managing kidney or heart failure
requires continued engagement in a set of behaviours.
Managing a chronic disease is therefore all about chang-
ing behaviour and sustaining new habits, not about mak-
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ing a decision at one point in time. Professionals are not
in equipoise. Clinical practice guidelines clearly delineate
how professionals should operate and what treatments
and behaviour changes they should recommend. Patients
however, often don't recognize that their current behav-
iours or lack of adoption of professionally recommended
changes may be in conflict with their long-term goals of
maximizing longevity or quality of life [34]. The profes-
sionals' task is to support the patient in understanding the
situation, to set agendas, to address ambivalences, and
ultimately to see the discrepancy between what they are
doing and ultimately want for themselves. The role of
approaches such as behaviour support interventions, such
as motivational interviewing and behaviour change coun-
selling, is clear in these situations. Some of the tools devel-
oped to help patients in this area have also been called
decision aids, but might need re-conceptualisation as a
different class of intervention [18,19].
Examining one example in depth, we consider a common
situation. An overweight 50 year-old lorry driver recently
diagnosed with diabetes is struggling to control his blood
pressure and weight. The patient also faces the challenge
of trying to give up smoking whilst also learning about
diabetes and balancing his own preferences and other
demands on his time. The clinician is an excellent com-
municator and, where he feels able, shares decisions with
patients. However, despite his respect for the patient's
right to autonomy and self-determination, the clinician
feels professional responsibility to explain risks and con-
sequences. Whereas there are opportunities to pose valid
choices (such as a range of smoking cessation methods, or
whether to prioritise weight loss versus blood pressure
control), the professional feels there is a larger overriding
goal and does not perceive the situation to be one of clin-
ical equipoise. His agenda is to modify the individuals'
risk profile and, although he aims to do that with sensitiv-
ity and tact, he nevertheless has a clear agenda to motivate
the patient to adopt a healthier lifestyle and to better man-
age a long-term condition.
The patient however is ambivalent about the problem. He
is knows many other drivers who have come to little harm
from smoking and, besides, a beer with his friends is a val-
ued escape from a tedious routine. He appreciates his cli-
nician's concern and does his best to adhere to an agreed
new medication regime, but he is, at best, ambivalent
about whether to attempt all the suggested changes. This
is a stark example perhaps, but dual equipoise is clearly
not present. For the professional, the evidence points in a
clear direction, while the patient has other competing pri-
orities and preferences. We contend that interventions
designed to deal with these kinds of problems are proba-
bly best regarded as behavioural support interventions
rather than decision support interventions. Motivational
interviewing and behaviour change counselling are good
examples of such approaches, and are interventions
aimed at supporting individuals to recognise actions that
are important to them and to gain confidence in being
able to sustain the behaviours over time [34]. This argu-
ment, in turn, brings us to a potential definition: behav-
ioural support interventions describe, justify, and
recommend actions that, over time, lead to predictable
outcomes over short, intermediate, and long-term time-
frames, and that have relevant and important conse-
quences for those who are considering behaviour change.
Definitions of decision and behaviour support 
interventions
From these two descriptive accounts, we move to compare
the two definitions and to discuss their implications.
Table 1 provides a summary of their key characteristics.
These descriptions are deliberately brief: they provide
only an outline of what such an intervention could even-
tually contain. The point is to draw attention to the issue
of dual equipoise as a design determinant. Dual equipoise
assumes that all parties in the decision space agree that
preferences are paramount--that there is sufficient equiva-
lence among options to allow personal preference to hold
sway. In addition, such decisions are discrete in that they
occur at a single time points, are often irreversible, and
commonly, relatively urgent. A decision to undergo a sur-
gical procedure, to have a test, to enter a screening pro-
gramme--all these are decisions where dual equipoise
exists, albeit to varying degrees, depending on ambient
professional or policy perspectives. There are many ways
in which interventions can be designed to address this
decision-making episode, ranging from a brief description
or comparison of options to elaborate interactive multi-
media website. It remains to be seen whether or not such
interventions will conform to standards such as those set
by IPDAS, or indeed whether the IPDAS collaboration is
nimble enough to adapt to innovations over time. At the
core of the definition however, which is the rationale for
putting it forward, is the assumption of dual equipoise,
and unless an intervention is clear about the nature of a
potential dual equipoise and the provenance of the evi-
dence on which it makes such a claim, we contend that it
cannot be classed as a decision support intervention.
In situations where dual equipoise does not exist, the
weight of evidence (or consensus) is such that a profes-
sional, to maintain professional and societal integrity, is
swayed to recommend an action or to motivate an action
or a change of behaviour. Helping a patient to achieve
good self-care in diabetes or in heart failure entails a series
of behaviours where benefits far outweigh risks, and
therefore, ultimately, the clinician is obliged to set out an
agenda that may be at odds with patient preferences. Sim-
ilarly, there are many ways in which interventions can be
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designed to address the task of providing support for a rec-
ommended action or behaviour. A time-honoured
method is the establishment of a continuing relationship
with a supportive, informed clinician, as is exemplified by
a primary care model. More recently, programmes that
support the development of self-care and self-manage-
ment have been developed [35-38]. Future programmes
will no doubt build on these interventions, by enhancing
patient motivation, creating patients capable of co-pro-
ducing healthcare, and engaging patients more closely in
monitoring their illness and reacting to data feedback
methods. At the core, however, is the assumption that
there are a set of actions and behaviours that will enhance
patient healthcare outcomes that are not episodic recur-
rent decisions, but rather are automatically integrated into
daily routines.
Decision and behaviour support interventions: 
implications
This article proposes new and separate definitions for
interventions that propose to help people arrive at high-
quality decisions and to initiate and maintain behaviours
that lead to improved outcomes in healthcare contexts.
We are aware of previous definitions and hope the argu-
ments put forward here help to clarify the debates sur-
rounding the scope of these methods and the terminology
being used. We further felt it necessary to clarify why these
two classes of interventions are different from each other
in terms of dual versus single equipoise, with the hope
that we will prevent researchers and developers lumping
together approaches that need different theoretical foun-
dations [39]. Developers need to design tools that are
clear about the different goals, characteristics, and motiva-
tions of users and place more emphasis on theories that
align with the different tasks of either undertaking delib-
erative choices or initiating and sustaining behaviour
change [40]. The important point here is that the theories
that can guide development of decision support interven-
tions (e.g., expected utility theory) are different from those
that should guide development of behaviour support
interventions (e.g., theory of planned behaviour, trans-
theoretical model).
Although we agree that patient-centeredness is wide
enough to apply to all health care interactions the concept
of shared decision making applies best to situations where
dual equipoise exists; behaviour change methods on the
other hand, such as motivational interviewing or behav-
iour change counselling, applies to situations where dual
equipoise is unavailable. We avoid going into more depth
about these kind of interventions: there is a vast literature,
and given the interest in self-management approaches to
chronic diseases, it is likely that behaviour support inter-
ventions and the potential to harness the power of feed-
back from monitoring techniques and personalised
interactive tools (web and telephony) will continue to be
an area for further development. The design of decision
support interventions, as they engage with web 2.0 and
wiki technologies is also at a stage of evolution, and
although standards are emerging, they will require modi-
fication as innovations and further research is published.
Summary
We believe that, over time, both decision and behaviour
support interventions will become important compo-
nents of healthcare pathways. However, as we hope to
Table 1: Definitions and key characteristics of decision and behaviour support interventions
Definitions Decision support interventions Behaviour support interventions
'Decision support interventions help people think about 
choices they face; they describe where and why choice 
exists, in short, conditions of dual equipoise; they provide 
information about options, including, where reasonable, the 
option of taking no action. These interventions help people 
to deliberate, independently or in collaboration with others, 
about options by considering relevant attributes; they 
support people to forecast how they might feel about short, 
intermediate, and long-term outcomes that have relevant 
consequences, in ways that help the process of constructing 
preferences and eventual decision making appropriate to 
their individual situation'
'behavioural support interventions describe, justify, and 
recommend actions that, over time, lead to predictable 
outcomes over short, intermediate, and long-term 
timeframes, and that have relevant and important 
consequences for those who are considering behaviour' 
change'.
Key characteristics Describe a decision where there is dual equipoise. Describe the consequences (risks) of different behaviours/
actions.
Options are clearly delineated. Options, if present, are ranked.
Option attributes are clearly delineated and compared. Describe a range of safe (risk reducing) behaviours/range of 
consequences of unsafe (risk enhancing) behaviours.
Intermediate and long-term outcomes described, using 
social, psychological, and biological consequences, and 
decision-making processes and interventions are provided at 
cross-road points.
Intervention involves interaction, data collection, and 
feedback over time to support behaviour modification.
A recommendation (decision or action) is avoided. A recommendation is generated, albeit negotiated.
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have demonstrated, they have divergent aims, different
relationships to equipoise and, by definition, form two
intervention classes: decision and behaviour support
interventions. By being clear about definitions and overall
goals, we hope that our ability to use appropriate theories
to design and evaluate their impact will also improve.
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